Era de Coronavirus Pandémico y Pacientes con Cáncer

Autores/as

  • Maria Tomás Microbiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), A Coruña, Spain. Spanish Society of Infectious Diseases and Clinical M2icrobiology (SEIMC). https://orcid.org/0000-0003-4501-0387

DOI:

https://doi.org/10.32635/2176-9745.RBC.2021v67n4.2430

Palabras clave:

Coronavirus, COVID-19, SARS-CoV-2, Pandemias, Neoplasias

Resumen

The SARS-CoV-2 virus and variants (Delta and Mu) will not be the last to provoke pandemics. To fight the new coronavirus species and SARS-CoV-2 variants, it will need to surge vaccination efforts, improve surveillance systems of animal reservoirs, use diagnostic efficiently and communicate consistently to health authorities. Cancer patients could develop new SARS-CoV-2 variants when full vaccination should be key to avoid such entanglement. The future of new pandemic around the world will depend on the development of the pan-coronavirus vaccines and the implementation of these measures across the globe.

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

2021-11-24

Cómo citar

1.
Tomás M. Era de Coronavirus Pandémico y Pacientes con Cáncer. Rev. Bras. Cancerol. [Internet]. 24 de noviembre de 2021 [citado 22 de noviembre de 2024];67(4):e-252430. Disponible en: https://rbc.inca.gov.br/index.php/revista/article/view/2430

Número

Sección

ARTÍCULOS DE OPINIÓN